Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Careful dosing and monitoring are crucial to prevent adrenal insufficiency when using ketoconazole for Cushing's disease.

Mitotane changes steroid breakdown, affecting cortisol availability.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Lower adiponectin levels are linked to higher insulin resistance in women with PCOS.

Testosterone treatment may affect heart response to stress in transgender men.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Finasteride causes temporary cell death in BPH tissues.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Doctors need to be better prepared to assess and treat obesity in patients.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Finasteride and minoxidil together promote hair growth better than either alone.

Finasteride doesn't affect erections much, but may decrease libido in men.